Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.

Journal of the International AIDS Society
Ariane van der StratenMTN-041/MAMMA Study Team

Abstract

Women in sub-Saharan Africa spend a substantial portion of their reproductive lives pregnant and/or breastfeeding (P/BF), yet they have limited options to prevent HIV during these maternal stages. In preparation for phase 3b prevention trials in P/BF women, we explored attitudes about using a vaginal ring or oral pills for pre-exposure prophylaxis (PrEP), perceptions of HIV risk during P/BF and key influences on future PrEP use. In 2018, we conducted 16 single-sex focus group discussions (FGDs) with community- and clinic-recruited HIV-uninfected women, currently or recently P/BF, aged 18 to 40, and men with (currently or recently) P/BF partners, aged 18+. Participants completed a behavioural questionnaire, viewed an educational video and handled prototype placebo products. FGDs were conducted in local languages and transcribed, coded and analysed, using a socio-ecological framework, for key influences on willingness to use products, HIV risk perceptions and opinions on product attributes. Of the 128 participants (65 women, 63 men) 75% lived with their partner and 84% had a child. Women reported the most important influencers when P/BF were partners, and all stated that health decisions when P/BF are typically made jointly (e.g....Continue Reading

References

Jul 26, 2011·AIDS·Nelly R MugoUNKNOWN Partners in Prevention HSV/HIV Transmission Study Team
Sep 17, 2014·Journal of the International AIDS Society·Ariane van der StratenElizabeth T Montgomery
Feb 24, 2016·The New England Journal of Medicine·Jared M BaetenUNKNOWN MTN-020–ASPIRE Study Team
Jun 2, 2016·Journal of the International AIDS Society·Ellen H LueckeUNKNOWN MTN-003D Study Team
Jul 13, 2016·Antimicrobial Agents and Chemotherapy·Lisa M NoguchiRichard H Beigi
Nov 10, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·John KinuthiaGrace John-Stewart
Dec 14, 2016·The New England Journal of Medicine·Annalene NelUNKNOWN Ring Study Team
Mar 30, 2017·International Journal of Environmental Research and Public Health·Catherine NdindaNene Ernest Khalema
Apr 1, 2017·Journal of the International AIDS Society·Dominika L SeidmanDeborah Cohan
Apr 26, 2017·AIDS·Elizabeth T MontgomeryUNKNOWN MTN-020/ASPIRE Study
Mar 6, 2018·The Journal of Infectious Diseases·Lynne M Mofenson
Jan 19, 2019·Culture, Health & Sexuality·Miria ChitukutaUNKNOWN MTN-020/ASPIRE Study Team
Jul 17, 2019·Drugs·Ioannis Hodges-MameletzisRachel Baggaley
Mar 8, 2020·Journal of the International AIDS Society·Jennifer VellozaUNKNOWN HPTN 082 study group
Mar 12, 2020·CJC Open·UNKNOWN Canadian Alliance for Healthy Hearts and Minds First Nations Cohort Research Team

❮ Previous
Next ❯

Citations

May 4, 2021·AIDS and Behavior·Marie C D StonerUNKNOWN MTN-020 ASPIRE and M-025 HOPE study teams

❮ Previous
Next ❯

Software Mentioned

Dedoose

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2022 Meta ULC. All rights reserved